Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 1
2000 2
2002 1
2003 1
2004 1
2007 2
2009 2
2010 2
2012 4
2013 2
2014 3
2015 4
2016 1
2017 4
2018 7
2019 6
2020 4
2021 3
2022 3
2023 6
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial.
Jørgensen KK, Olsen IC, Goll GL, Lorentzen M, Bolstad N, Haavardsholm EA, Lundin KEA, Mørk C, Jahnsen J, Kvien TK; NOR-SWITCH study group. Jørgensen KK, et al. Lancet. 2017 Jun 10;389(10086):2304-2316. doi: 10.1016/S0140-6736(17)30068-5. Epub 2017 May 11. Lancet. 2017. PMID: 28502609 Clinical Trial.
Differential sensitivity of the 2020 revised comprehensive diagnostic criteria and the 2019 ACR/EULAR classification criteria across IgG4-related disease phenotypes: results from a Norwegian cohort.
Vikse J, Midtvedt Ø, Fevang BS, Garen T, Palm Ø, Wallenius M, Bakland G, Norheim KB, Molberg Ø, Hoffmann-Vold AM. Vikse J, et al. Arthritis Res Ther. 2023 Sep 5;25(1):163. doi: 10.1186/s13075-023-03155-y. Arthritis Res Ther. 2023. PMID: 37670401 Free PMC article.
Structured patient care pathway for gout.
Lianes O, Nystad TW, Røen SA, Fevang BS. Lianes O, et al. Tidsskr Nor Laegeforen. 2020 Feb 3;140(2). doi: 10.4045/tidsskr.19.0078. Print 2020 Feb 4. Tidsskr Nor Laegeforen. 2020. PMID: 32026858 Free article. English, Norwegian.
A review of national shoulder and elbow joint replacement registries.
Rasmussen JV, Olsen BS, Fevang BT, Furnes O, Skytta ET, Rahme H, Salomonsson B, Mohammed KD, Page RS, Carr AJ. Rasmussen JV, et al. Among authors: fevang bt. J Shoulder Elbow Surg. 2012 Oct;21(10):1328-35. doi: 10.1016/j.jse.2012.03.004. Epub 2012 Jun 11. J Shoulder Elbow Surg. 2012. PMID: 22694880 Review.
Exploring the impact of the national tender system on the use of costly drugs treating rheumatoid arthritis patients in ten rheumatology centers in Norway (2010-2019).
Brkic A, Diamantopoulos AP, Hoff M, Haavardsholm EA, Fevang BTS, Brekke LK, Loli L, Zettel C, Bakland G, Mielnik P, Haugeberg G. Brkic A, et al. Among authors: fevang bts. BMC Health Serv Res. 2023 Sep 7;23(1):968. doi: 10.1186/s12913-023-09975-7. BMC Health Serv Res. 2023. PMID: 37679747 Free PMC article.
Increased Incidence of Giant Cell Arteritis in Urban Areas?
Brekke LK, Fevang BT, Myklebust G. Brekke LK, et al. Among authors: fevang bt. J Rheumatol. 2019 Mar;46(3):327-328. doi: 10.3899/jrheum.180714. Epub 2019 Jan 15. J Rheumatol. 2019. PMID: 30647168 No abstract available.
Good function after shoulder arthroplasty.
Fevang BT, Lygre SH, Bertelsen G, Skredderstuen A, Havelin LI, Furnes O. Fevang BT, et al. Acta Orthop. 2012 Oct;83(5):467-73. doi: 10.3109/17453674.2012.720118. Epub 2012 Sep 5. Acta Orthop. 2012. PMID: 22950481 Free PMC article.
Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trial.
Goll GL, Jørgensen KK, Sexton J, Olsen IC, Bolstad N, Haavardsholm EA, Lundin KEA, Tveit KS, Lorentzen M, Berset IP, Fevang BTS, Kalstad S, Ryggen K, Warren DJ, Klaasen RA, Asak Ø, Baigh S, Blomgren IM, Brenna Ø, Bruun TJ, Dvergsnes K, Frigstad SO, Hansen IM, Hatten ISH, Huppertz-Hauss G, Henriksen M, Hoie SS, Krogh J, Midtgard IP, Mielnik P, Moum B, Noraberg G, Poyan A, Prestegård U, Rashid HU, Strand EK, Skjetne K, Seeberg KA, Torp R, Ystrøm CM, Vold C, Zettel CC, Waksvik K, Gulbrandsen B, Hagfors J, Mørk C, Jahnsen J, Kvien TK. Goll GL, et al. Among authors: fevang bts. J Intern Med. 2019 Jun;285(6):653-669. doi: 10.1111/joim.12880. Epub 2019 Apr 12. J Intern Med. 2019. PMID: 30762274 Free PMC article. Clinical Trial.
53 results